ARCA gets FDA nod to test anti-clotting drug for COVID patients
WESTMINSTER — ARCA Biopharma Inc. (Nasdaq: ARCA) received approval from the U.S. Food and Drug Administration to begin an advanced […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
ARCA Biopharma submits anti-blood clotting drug to FDA as potential COVID treatment
WESTMINSTER — Gene therapy maker ARCA biopharma Inc. (Nasdaq: ABIO) has filed an initial application to study whether its anti-blood…
Spur-of-the-moment decision results in Louisville startup
LOUISVILLE — He had a choice while driving over a bridge in Yemen where he was studying Arabic. Either hit…
Climate ‘game-changer’
High atop Table Mesa in southwest Boulder, visitors to the National Center for Atmospheric Research enjoy more than just a…
Climate ‘game-changer’
High atop Table Mesa in southwest Boulder, visitors to the National Center for Atmospheric Research see more than just a…